The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Differential diagnosis of hematologic and solid tumors using targeted transcriptome and artificial intelligence.
 
Hong Zhang
Employment - Genomic Testing Cooperative
Consulting or Advisory Role - EDP Biotech
 
Maher Albitar
Employment - Genomic Testing Cooperative
Leadership - Genomic Testing Cooperative
Stock and Other Ownership Interests - Genomic Testing Cooperative
Patents, Royalties, Other Intellectual Property - Multiple patents on methods in diagnostics
Travel, Accommodations, Expenses - Genomic Testing Cooperative
 
Muhammad Asif Qureshi
No Relationships to Disclose
 
Mohsin Wahid
No Relationships to Disclose
 
Ahmad Charifa
Employment - Genomic Testing Cooperative
 
Aamir Ehsan
Employment - CorePath Laboratories
 
Andrew Ip
Stock and Other Ownership Interests - Merck (I)
Consulting or Advisory Role - TG Therapeutics
Speakers' Bureau - AstraZeneca
(OPTIONAL) Uncompensated Relationships - COTA; Genomic Testing Cooperative
 
Ivan De Dios
Employment - Genomic Testing Cooperative
 
Wanlong Ma
Employment - Genomic Testing Cooperative
 
James McCloskey
No Relationships to Disclose
 
Michele Donato
Research Funding - Merck (Inst)
 
David Samuel DiCapua Siegel
Stock and Other Ownership Interests - Celularity
Consulting or Advisory Role - Bristol-Myers Squibb; Celularity; Janssen Oncology; Karyopharm Therapeutics; Neximmune; Takeda
Speakers' Bureau - Bristol-Myers Squibb; GlaxoSmithKline; Janssen Oncology; Takeda
 
Martin Gutierrez
Stock and Other Ownership Interests - Cota Healthcare
Speakers' Bureau - BMS; Lilly; Merck
Research Funding - Acerta Pharma (Inst); Adlai Nortye (Inst); Arcus Biosciences (Inst); Array BioPharma (Inst); Bayer (Inst); Bellicum Pharmaceuticals (Inst); BMS (Inst); Boehringer Ingelheim (Inst); Celgene (Inst); Checkpoint Therapeutics (Inst); Compass Therapeutics (Inst); Constellation Pharmaceuticals (Inst); Cullinan Oncology (Inst); Cyteir (Inst); Daiichi Sankyo Company (Inst); Eisai (Inst); EMD Serono (Inst); EMD Serono (Inst); Erasca, Inc (Inst); Fate Therapeutics (Inst); Georgetown Univ. (Inst); GlaxoSmithKline (Inst); GSB Pharma (Inst); Hackensack Meridian Health (Inst); Imugene (Inst); Incyte (Inst); Incyte (Inst); Infinity Pharmaceuticals (Inst); ITeos Therapeutics (Inst); Janssen (Inst); Johnson & Johnson (Inst); KSQ Therapeutics (Inst); MedImmune (Inst); Memorial Sloan-Kettering Cancer Center (Inst); Merck (Inst); Millennium (Inst); Mirati Therapeutics (Inst); Moderna Therapeutics (Inst); NextCure (Inst); NextCure (Inst); Nimbus Therapeutics (Inst); Pfizer (Inst); Pharmacyclics (Inst); Rapa Therapeutics (Inst); Regeneron (Inst); Roche/Genentech (Inst); Sanofi (Inst); Seagen (Inst); Silenseed (Inst); Silenseed (Inst); Synlogic (Inst); Tesaro (Inst); Turning Point Therapeutics (Inst); Vedanta Biosciences (Inst); VelosBio (Inst); Verastem (Inst); Vincerx Pharma (Inst)
Travel, Accommodations, Expenses - Guardant Health
 
Andrew L Pecora
Employment - Cota Healthcare; Regional Cancer Care Associates
Leadership - Cota Healthcare; Regional Cancer Care Associates
Stock and Other Ownership Interests - Cota Healthcare; Regional Cancer Care Associates
Honoraria - Bristol-Myers Squibb
Consulting or Advisory Role - Bristol-Myers Squibb
Speakers' Bureau - Bristol-Myers Squibb
Research Funding - Bristol-Myers Squibb (Inst)
Patents, Royalties, Other Intellectual Property - Cd34 patents COTA patents
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Andre Goy
Employment - OM Pharmaceutical Industries; Regional Cancer Care Associates
Leadership - COTA; Genomic Testing Cooperative; Resilience Care
Stock and Other Ownership Interests - COTA; Genomic Testing Cooperative; Resilience Care
Consulting or Advisory Role - AstraZeneca; Elsevier; Gilead Sciences; Janssen; Kite, a Gilead company (Inst); OncLive Peer Exchange; Physicans' Education Resource; Resilience Care; Vincera Pharma/Vincerx Pharma
Speakers' Bureau - Bristol-Myers Squibb/Celgene
Research Funding - Acerta Pharma (Inst); AstraZeneca (Inst); Celgene (Inst); Constellation Pharmaceuticals (Inst); Genentech/Roche (Inst); Infinity Pharmaceuticals (Inst); Infinity/Verastem (Inst); Janssen (Inst); Karyopharm Therapeutics (Inst); Kite/Gilead (Inst); Pharmacyclics (Inst)
Expert Testimony - AstraZeneca
Travel, Accommodations, Expenses - Physicans' Education Resource
Other Relationship - AstraZeneca; MorphoSys/Incyte